Sequential intravesical gemcitabine and docetaxel versus bacillus Calmette-Guerin for the treatment of high-risk, treatment-naive, non-muscle invasive bladder cancer.

被引:0
|
作者
McElree, Ian M.
Steinberg, Ryan L.
Mott, Sarah L.
O'Donnell, Michael A.
Packiam, Vignesh T.
机构
[1] Univ Iowa, Carver Coll Med, Iowa City, IA USA
[2] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
[3] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
497
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer
    Obara, Wataru
    Hara, Isao
    Kato, Yoichiro
    Kato, Renpei
    Inoue, Keiji
    Sato, Fuminori
    Mimata, Hiromitsu
    Nakamura, Yusuke
    Fujioka, Tomoaki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (09) : 1371 - 1380
  • [42] FAILURE OF BACILLUS CALMETTE-GUERIN THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER: DEFINITION AND TREATMENT OPTIONS
    Gual Frau, Josep
    Palou, Joan
    Rodriguez, Oscar
    Parada, Ruben
    Breda, Alberto
    Villavicencio, Humberto
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (07): : 423 - 433
  • [43] The Management of Bacillus Calmette-Guerin (BCG) Failure in High-Risk Non-muscle Invasive Bladder Cancer: A Review Article
    Kodera, Ahmed
    Mohammed, Mahmoud
    Lim, Paul
    Abdalla, Omer
    Elhadi, Mohammed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [44] Bacillus Calmette-Guerin versus Gemcitabine for Intravesical Therapy in High-Risk Superficial Bladder Cancer: A Randomised Prospective Study
    Porena, Massimo
    Del Zingaro, Michele
    Lazzeri, Massimo
    Mearini, Luigi
    Giannantoni, Antonella
    Bini, Vittorio
    Costantini, Elisabetta
    UROLOGIA INTERNATIONALIS, 2010, 84 (01) : 23 - 27
  • [45] Intravesical Gemcitabine for Treatment of Superficial Bladder Cancer not Responding to Bacillus Calmette-Guerin Vaccine
    Elkoushy, M. A.
    AFRICAN JOURNAL OF UROLOGY, 2010, 16 (04) : 110 - 116
  • [46] Intravesical Chemohyperthermia Versus Bacillus Calmette-Guerin Instillation for Intermediate- And High-Risk Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
    Zhao, H.
    Chan, V. W. S.
    Castellani, D.
    Chan, E. O. T.
    Ong, W. L. K.
    Peng, Q.
    Moschini, M.
    Krajewski, W.
    Pradere, B.
    Ng, C. F.
    Enikeev, D.
    Vasdev, N.
    Ekin, G.
    Sousa, A.
    Leon, J.
    Guerrero-Ramos, F.
    Tan, W. S.
    Kelly, J.
    Shariat, S. F.
    Witjes, J. A.
    Teoh, J. Y. C.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [47] Intravesical chemohyperthermia versus bacillus calmette-guerin instillation for intermediate- and high-risk non-muscle invasive bladder cancer: A systematic review and meta-analysis
    Zhao, H.
    Chan, V. W.
    Castellani, D.
    Chan, E. O.
    Ong, W. L. K.
    Peng, Q.
    Moschini, M.
    Krajewski, W.
    Pradere, B.
    Ng, C.
    Enikeev, D.
    Vasdev, N.
    Ekin, G.
    Sousa, A.
    Leon, J.
    Guerrero-Ramos, F.
    Tan, W.
    Kelly, J.
    Shariat, S. F.
    Witjes, J.
    Teoh, J. Y.
    EUROPEAN UROLOGY, 2021, 79 : S1068 - S1069
  • [48] A MULTI-INSTITUTIONAL ANALYSIS OF PATIENT OUTCOMES FOLLOWING INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Sangster, Pippa
    Symes, Andrew
    Walker, Roger
    Morley, Roland
    Thompson, Alan
    Dick, John
    Le Roux, Peter
    Sandhu, Sarb
    JOURNAL OF UROLOGY, 2010, 183 (04): : E524 - E524
  • [49] Intravesical Bacillus Calmette-Guerin in combination with an Interferon-alpha versus intravesical Bacillus Calmette-Guerin for the Treatment of non-muscle-invasive Bladder Cancer Comment on a recently published Cochrane Review
    Kunath, Frank
    UROLOGE, 2017, 56 (08): : 1031 - 1033
  • [50] Comparison of hyperthermic intravesical chemotherapy and Bacillus Calmette-Guerin therapy in high-risk non-muscle invasive bladder cancer: a matched-pair analysis
    Pazir, Yasar
    Esmeray, Abdullah
    Caglar, Ufuk
    Erbin, Akif
    Ozgor, Faruk
    Sarilar, Omer
    Akbulut, Fatih
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (03) : 957 - 963